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INTRODUCTION 
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The pathogenesis of the inflammatory bowel diseases (IBD), ulcerative 
colitis and Crohn’s disease is still incompletely understood. It is likely that pro-
inflammatory cytokine and chemokine release and derangement of immune 
responses, along with genetic factors, play a role in the inflammatory processes.  
In addition to these factors, it has long been speculated that the local 
release of reactive oxygen species may also be involved, creating epithelial and 
vascular injury in the colon. It is therefore possible that endogenous protective 
antioxidant systems could be evoked in order to attenuate colonic tissue injury 
under such conditions. 
 One such system is the microsomal inducible enzyme, heme oxygenase-1 
(HO-1), which converts heme into biliverdin, carbon monoxide (CO) and free 
ferrous iron, the biliverdin product beeing subsequently reduced to bilirubin. 
HO-1 can provide an endogenous protective anti-oxidant system related to the 
increase in biliverdin and bilirubin, which possess anti-oxidant and anti-
complement activity and which can reduce lipid peroxidation. 
 Preparations of aminosalicylates, exemplified by 5-aminosalicylic acid (5-
ASA), for oral and colonic administration have been used over many decades 
for the treatment of the inflammatory bowel diseases, ulcerative colitis and 
Crohn’s disease. Despite its long term and wide-spread use, the mechanisms 
underlying the anti-colitic actions of 5-ASA have not been fully identified. 
However, an enduring concept is that at least part of the beneficial activity of 5-
ASA reflects its actions as an anti-oxidant and free radical scavenger. Thus, the 
generation and release of local reactive oxygen species have long been 
considered to be involved in the vascular, epithelial and mucosal inflammatory 
injury in colitis and hence scavenging these moieties offers a potential 
mechanism of action of 5-ASA.  
The present study investigates whether the beneficial effects in vivo could 
involve induction of heme oxygenase-1, known to provide endogenous anti-
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oxidant and anti-inflammatory moieties which can modulate colonic 
inflammation. The therapeutic activity in colitis may also reflect additional 
pharmacological actions to up-regulate endogenous anti-oxidant and anti-
inflammatory systems.  
In our work we have studied a well-known colitis model to know more 
information about the defence mechanisms, mainly the HO enzyme system in 
the inflammatory processes. 
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AIMS 
 
In our experiments we used a widespread colitis model, the 2,4,6 
trinitrobenzene sulphonic acid (TNBS) model in rats. 
In the first part of the study we examined 
 the time dependence of HO activity, and HO-1 expression 
 the effect of HO-1 inducers (heme, cadmium chloride), and a HO-1 
inhibitor (zinc protoporphyrin-ZnPP) on the colonic inflammatory 
damage (lesion, myeloperoxidase (MPO) activity). 
In the next part we studied the effect of 5-aminosalicylic acid (5-ASA), the 
active therapeutic moiety of a number of clinically used anti-colitic agents on 
 the TNBS induced colonic inflammatory damage (lesion, colon weight, 
MPO activity, tumour necrosis factor-α (TNF-α) levels). 
 the HO-1 enzyme expression and on the heme oxygenase activity. 
 Finally we examined the effects of a heme oxygenase inhibitor, ZnPP on 
the effect of 5-ASA. We have measured  the colonic inflammatory 
damage (lesion, MPO activity) as well as the HO activity. 
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METHODS 
 
Induction of colitis and pharmacological treatments 
 
Male Wistar rats (200-250 g) were randomised before commencement of 
the study, housed in groups and inspected and weighed every day. Food was 
withdrawn overnight for 12h prior to TNBS administration only, but the rats 
were allowed free access to drinking water. Under transient ether-induced 
anaesthesia, 2,4,6 trinitrobenzene sulphonic acid (TNBS; 30 mg or 10 mg in 250 
μl 50 %-os ethanol, v/v) was administered intra-rectally through an 8 cm long 
soft plastic catheter. The distal colon was dissected, photographed, processed 
and stored appropriately for subsequent analyses at different time points.  
Heme (30 μmol/kg), zinc protoporphyrin (ZnPP; 50 μmol/kg), or cadmium-
chloride (CdCl2; 2 mg/kg) were administered subcutaneously (s.c.), 18 h before  
TNBS (30mg) challenge, again at time of TNBS instillation and then once daily 
for 1 to 10 days. Heme and ZnPP were dissolved in sodium hydroxide (0,1 N) 
and sodium chloride (0,9 %) and pH adjusted to pH 7.4, with the concentration 
of the stock solutions being 0,5 mg/ml. Cadmium chloride was dissolved in 
distilled water.  
5-Aminosalicylic acid (5-ASA; 8.3, 25, 75 mg/kg) prepared freshly in 1% 
carboxymethylcellulose (CMC), was administered once daily in a volume of 
0,25 ml into the colon, 24 h and 3 h before TNBS challenge and 24 h after 
TNBS challenge. In studies on the effects of heme oxygenase inhibitor, zinc 
protoporphyrin (ZnPP) was administered at a dose of 50 μmol/kg, s.c. 18 h 
before TNBS challenge, again at time of TNBS instillation and 24 h after TNBS 
challenge. 
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Macroscopic and enzymatic assessment of the severity of colitis 
 
Measurement of macroscopic colonic inflammatory damage 
In all experimentel groups, the distal 8 cm portion of the colon (measured 
from the rectum) was removed, opened longitudinally and gently rinsed with 
ice-cold phosphate buffer (pH 7.4), blotted, weighed (Scaltec, Germany) and 
photographed (Samsung, Digimax 340, digital camera). The extent of 
macroscopically apparent inflammation, ulceration and tissue disruption was 
determined in a randomised manner from the colour images via computerised 
planimetry (Scion Image B4.02 version; Scion Corp.). The area of 
macroscopically visible mucosal involvement was calculated and expressed as 
the percentage of the total colonic segment area under study.  
In all experimental groups, immediately after photography, the 8 cm long 
segment of the distal colon were cut longitudinally into 8 cm long strips. These 
strips included both the macroscopically inflamed and non-inflamed areas and 
were used to determine myeloperoxidase (MPO) and heme oxygenase (HO) 
enzyme activity and HO-1 protein expression. 
 
Myeloperoxidase activity 
MPO levels were measured as an index of neutrophilic infiltration. MPO 
was expressed as mU mg/protein. 
 
Tumour necrosis factor-α levels 
The TNF-α levels were determined with quantitative TNF-α solid-phase 
Enzyme Linked ImmunoSorbent Assay (ELISA). The samples were measured 
spectrophotometrically at 450nm and were diluted with the buffer included in 
the assay kit (Hycult Biotechnology d.v. 5405 Uden, The Netherlands). The 
TNF-α values were expressed as pg/mg protein. 
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Western blotting for HO-1 expression 
Heme oxygenase-1 expression was measured by Western blotting 
technics. Results were determined by densitometry of the Western blots. 
 
Heme oxygenase activity 
Heme oxygenase activity was assessed by measuring bilirubin formation. 
One unit of heme oxygenase activity was defined as the amount of bilirubin 
(nmol) produced per hour per mg protein. 
 
Protein determination 
We have used Bradford’s method. Protein level was expressed as mg 
protein/ml. 
 
Statistical analysis 
For statistical comparisons, the two-tailed Student’s t-test and the analysis 
of variance with the Bonferroni test were used. 
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RESULTS AND DISCUSSION 
 
In the present study, transitory increase in HO-1 expression and heme 
oxygenase activity was observed in animals challenged with 50% ethanol, the 
vehicle used for the TNBS challenge. Such ethanol –induced actions may help 
explain the early biphasic response of the HO-1 enzyme activity following 
TNBS challenge. Moreover, these findings with ethanol could also suggest that 
HO-1 induction could be a general stress-driven pathway induced by challenge 
with a range of injurious substances although this will need to be explored 
further. 
Daily administration of the endogenous substrate of heme oxygenase and 
the known HO-1 inducer, heme, caused a substantial induction in HO-1 and 
heme oxygenase enzyme activity. This was accompained by a significant 
decrease in the macroscopically apparent mucosal damage in the colon, and a 
decrease in colonic MPO activity. Similar colonic protective actions to heme in 
the TNBS model were observed with the heavy metal, cadmium chloride in the 
current work. Whether the observed effect of heme could reflect a patho-
physiological feed-back mechanism involving these endogenous agents, along 
with reactive oxygen species, to promote HO-1 activity and hence to offset the 
inflammatory process, is not yet known. 
 In contrast to the effects of HO-1 induction, pharmacological approaches 
to reduce HO-1 activity by the administration of zinc protoporphyrin, a non-
physiological metalloporphyrin, have shown a substantial aggravation of the 
colonic inflammation, with colonic mucosal damage being greater than 80% of 
the area studied. This treatment also provoked a concomitant increase in MPO 
activity. This inhibition of heme oxygenase activity and concurrent detrimental 
effects of ZnPP were seen over the full 10 days treatment period. These findings 
would suggest that the pathophysiological induction of HO-1 in colitis does 
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indeed play a role in modulating the severity of the colonic inflammation over 
both acute and chronic periods.  
 Intracolonic daily doses of 5-ASA of 8,3 to 75 mg/kg, commencing 24 h 
prior to challenge with TNBS were found to be effective. To see better effect we 
decreased the dose of TNBS. Dose of TNBS of 10 mg caused significant 
macroscopic damage, but the animals showed more sensitivity to the 5-ASA 
treatment. A significant reduction of macroscopic lesion area and its severity in 
terms of a macroscopic score, as well as a fall in the elevated colon weight as an 
index of oedema, was observed with all doses of 5-ASA. In addition, a reduction 
in colonic MPO levels, an index of neutrophilic infiltration, as well as the 
inflammatory biomarker, TNF-α was achieved at the two higher dose levels of 
5-ASA investigated.  
Intracolonic administration of 5-ASA in anti-colitic doses caused a dose-
dependent increase in heme oxygenase activity in the inflamed colon, with the 
higher dose of 5-ASA causing an approximately two-fold increase in heme 
oxygenase activity. This dose of 5-ASA likewise caused a significant increase in 
the colonic expression of HO-1 protein in the TNBS-challenged rats, indicating 
that the increased heme oxygenase enzyme activity was probably a reflection of 
the production of new protein rather than simply a local co-factor or facilitatory 
action of 5-ASA on existing enzyme, although this awaits direct evaluation.   
Studies on the unchallenged rat colon following daily intracolonic 
administration of 5-ASA demonstrated a significant increase in HO-1 protein 
expression as well as in heme oxygenase enzyme activity. Such direct actions of 
5-ASA on the colonic heme oxygenase int he absence of invading inflammatory 
cells and detectible tissue injury suggest another class of inducers, in addition to 
the known range compounds including the substrate, heme, and the more 
classical agents such as heavy metals, nitric oxide donors and free radicals 
themselves. The processes by with such induction of this heat shock protein is 
brought about are not yet known. 
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Administration of ZnPP, in doses that inhibited HO-1 under these 
conditions, prevented the therapeutic effect of 5-ASA, as indicated by the 
abolition of the reduction in damage area and the colonic MPO levels. Although 
non-specific actions of this heme oxygenase inhibitor on colonic injury or on the 
action of 5-ASA cannot yet be excluded, these findings support the suggestion 
that the beneficial property of 5-ASA in this model involves the activity of HO-
1. 
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SUMMARY 
 
Our present study has confirmed that the endogenous anti-oxidant and 
anti-inflammatory enzyme, HO-1 is induced in the TNBS model of colitis in 
rats. This expression of HO-1 was further enhanced by the administration of 
heme, and cadmium chloride, which attenuated the extent of colonic damage 
and inflammation. In contrast, down regulation of HO-1 activity with a known 
inhibitor of such activity, zinc protoporphyrin, evoked an increase in 
inflammation and colonic damage.  
Our results thus suggest that 5-ASA could exert its colonic anti-
inflammatory effect, at least in part, through the up-regulation of colonic HO-1 
activity. However, whether these present findings in vivo in the rat colon 
following treatment with 5-ASA can be translated into an understanding of the 
therapeutic effects of the various 5-ASA preparations in colitic patients awaits 
further study. However, earlier preliminary in vitro studies have demonstrated in 
human colonic epithelial cells that HO-1 mRNA expression is stimulated by 
micromolar concentrations of 5-ASA.  
These current findings thus prompt for further investigation into the 
mechanisms of action underlying the ability of 5-ASA to affect the HO-1 
system. Such studies could thus yield additional pharmacological and molecular 
targets for rational improvement on the classical aminosalicylates for the therapy 
of colitis.  
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